Apollo Commercial Real Estate Finance (ARI) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Q2 2024 distributable earnings were $0.35 per share and GAAP net income was $33 million, or $0.23 per diluted share.
Total loan portfolio at quarter end was $8.3 billion, with 95% in first mortgages and 96% floating rate loans.
$759 million in loan repayments received in the first half of 2024; $505 million redeployed into four new transactions in Q2, plus two UK deals post-quarter totaling GBP 270 million.
Declared a quarterly dividend of $0.35 per share, representing a 13.9% yield.
No corporate debt maturities until May 2026, supporting a stable capital structure.
Financial highlights
Book value per share was $13.20 at June 30, 2024, down from $14.43 at December 31, 2023, mainly due to increased CECL allowances and share repurchases.
Repurchased $38 million of common stock at $10.16 per share in Q2, with an additional $2 million post-quarter.
Net interest income for Q2 2024 was $51.8 million; total assets at June 30, 2024 were $9.27 billion.
Ended the quarter with $193 million in liquidity and $507 million in unencumbered assets.
Gross add-on fundings in Q2 were $116 million; $438 million year-to-date.
Outlook and guidance
Portfolio expected to remain roughly flat for the remainder of 2024, with active capital recycling and robust pipeline.
2025 anticipated to be more active if economic conditions stabilize and interest rates moderate.
Anticipates recording a Specific CECL Allowance of approximately $90 million on a Massachusetts healthcare loan due to bankruptcy.
Management highlighted a conservative capital management strategy and focus on first mortgage, floating rate loans.
$436.6 million of unfunded loan commitments remain, expected to be funded over a 2.6-year weighted-average tenor.
Latest events from Apollo Commercial Real Estate Finance
- $8.8B loan portfolio, 9.4% yield, and robust Apollo backing drive strong performance.ARI
Investor presentation9 Mar 2026 - Shareholders to vote on $9B asset sale to Athene, revised management fees, and future strategy.ARI
Proxy Filing9 Mar 2026 - Shareholders are asked to approve a $9B commercial loan sale to Athene, offering higher yields.ARI
Proxy Filing20 Feb 2026 - Portfolio sale prompts asset value maximization and strategic review, with shareholder vote pending.ARI
Proxy Filing12 Feb 2026 - 2025 net income was $114M; full loan portfolio sale to Athene at 99.7% of commitments.ARI
Q4 202511 Feb 2026 - Stockholders to vote on $9B asset transfer to Athene, aiming to enhance value and efficiency.ARI
Proxy Filing10 Feb 2026 - Proposed $9B real estate loan portfolio acquisition highlights disciplined, long-term strategy.ARI
Proxy Filing6 Feb 2026 - $9B real estate loan portfolio acquired with robust oversight and long-term investment focus.ARI
Proxy Filing6 Feb 2026 - $9B loan portfolio sale at 99.7% unlocks $1.4B cash, validates book, and enables strategic review.ARI
Status update3 Feb 2026